AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline
Coverage timeline
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Related events
Related events
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
1 report1 sourceSimilarity 0.38
Every Cure’s drug repurposing strategy isn't what you think, and it could change rare disease treatment
When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that challenged the traditional research model.
CNBC
1 report1 sourceSimilarity 0.25
Why memory chip stocks are getting hit hard for the second day in a row
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
CNBC
25 reports12 sourcesSimilarity 0.24
Iran war rages, Strait of Hormuz still blocked as Trump pushes for a deal
The Trump administration expects Iran's formal response to its 15-point peace proposal today, as Tehran continues blocking the Strait of Hormuz. Grouped from 25 articles across 12 sources.
ABC Australia, ABC News, Al Jazeera +9
2 reports2 sourcesSimilarity 0.23
Fans rethink driving to SA for AFL Gather Round as global fuel crisis continues
The SA government and AFL are in discussions to try to keep fans flocking to Adelaide for next month's AFL Gather Round, as the global fuel crisis threatens to disrupt travel plans. Grouped from 2 articles across 2 sources.
ABC Australia, Al Jazeera
1 report1 sourceSimilarity 0.23
Do we actually have the workforce for the $4b NDIS alternative?
Months away from the start of a huge shift in disability support for children, the workforce expected to deliver it has concerns about its readiness.
ABC Australia
1 report1 sourceSimilarity 0.22
Strategy is accelerating its crypto purchases as rivals sit on the sidelines
Demand for bitcoin as a corporate treasury asset is once again concentrated in Michael Saylor's Strategy as the company steps up its bitcoin buying pace.
CNBC